Amiri, Hamed
Javid, Hossein
Einafshar, Elham
Ghavidel, Farideh
Rajabian, Arezoo
Hashemy, Seyed Isaac https://orcid.org/0000-0002-1323-5250
Hosseini, Hossein https://orcid.org/0000-0003-4859-7291
Funding for this research was provided by:
Mashhad University of Medical Sciences, Mashhad, Iran (401034, 401034, 401034, 401034, 401034, 401034, 401034)
Article History
Accepted: 20 February 2024
First Online: 27 February 2024
Declarations
:
: Not applicable.
: The authors declare no competing interests.
: This declaration confirms that the usage of PC-3 prostate cancer cells in the study has been conducted in accordance with the relevant ethical principles, guidelines, and regulations.